BioNTech
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Germany · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
An Der Goldgrube 12, Mainz, Rheinland-Pf...Phone Number
+49613190840Website
www.biontech.comRevenue
$3.2 BillionStock Symbol
BNTXIndustry
ZI Rank: 3
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
6
2
2
4
3
3
About BioNTech
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseasesExplore more
BioNTech Org Chart
UG
Senior Director, Clinical Development Lead
SS
Senior Director
AH
Senior Director & Global Clinical Development...
RC
Senior Director and Business Partner for Qual...
SM
Senior Director, Clinical Science
LA
Senior Director
HH
Director, Clinical Development
NM
Director
DA
Director, Medical Safety
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioNTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if BioNTech had a recent Job posting/layoffs
BioNTech, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BioNTech is spiking on competitors!
Funding: Get notified immidiatlly once BioNTech has new funding data
Earning: See what the market has to say on BioNTech recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at BioNTech
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when BioNTech launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if BioNTech has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at BioNTech
Find 2 more new buyers
Company Profile Activity
Activity Insights
BioNTech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioNTech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioNTech.
BioNTech financials insights
Gather financial insights about BioNTech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$270M
2019
Series B
$325M
Other Financing Round
$55.7M
2020
Multiple Rounds
$694.8M
BioNTech Tech Stack
A closer look at the technologies used by BioNTech
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Person-Based
Research & Development
BioNTech News & Media
BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?
BioNTech SE (NASDAQ:BNTX) is ending a mid-stage study of its personalized mRNA cancer vaccine, autogene cevumeran, after an independent monitoring committee concluded that continuing the trial was unlikely to demonstrate effectiveness. The decision is more concerning than a routine trial disappointment because the committee identified a numerical imbalance in overall survival between the study groups. […]BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?
Both have attracted considerable attention from Wall Street recently.BioNTech Kills a Cancer Trial Roche Helped Build
One colorectal failure does not destroy the platform, but it exposes how brutally tumor biology can defeat elegant technology.BioNTech (BNTX) Rallied on Moderna’s Win. Does a Competitor’s Success Validate its Oncology Pipeline?
BioNTech SE (NASDAQ:BNTX) rallied following the first positive interim Phase 3 topline result for a personalized mRNA cancer therapy. Moderna and Merck said intismeran, combined with Keytruda, significantly improved recurrence-free and distant metastasis-free survival in patients with surgically removed high-risk melanoma. The result lifted other mRNA developers because it provided the strongest evidence yet that […]
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioNTech
Sign Up For FreeTo access detailed company insights
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases... Read More
